EUVIMEDEUVIMED entdecken
CrossrefInfokarte

A Risk Score without a Window: The Clinical Timing Problem of Observatoire Régional Breton sur l’Infarctus Risk Score

Sarah Louise Duus Holle, Helle Søholm, Martin Frydland, Mikkel Bjerg Andersen, Yusuf Abdi Isse, Joakim Bo Kunkel, Anika Klein, Lene Holmvang, Jacob Eifer Møller, Christian Hassager, Rasmus Paulin Beske

Cardiology · 2026-05-18 · 1-12

DOI: 10.1159/000552034 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Cardiogenic shock (CS) is a main cause of mortality in ST-elevation myocardial infarction (STEMI). The ORBI risk score estimates in-hospital CS risk using pre- and post-procedural angiographic variables. The study aimed to prospectively validate the ORBI risk score for predicting in-hospital CS and to assess its ability to identify post-procedural CS, when all score components are available. Methods: Consecutive adult STEMI patients without CS at admission were prospectively registered at a tertiary hospital during 2022–2025. Discrimination and calibration were evaluated in all patients and among patients with post-procedural CS after leaving the catheterization laboratory. Results: Among 2,713 adult patients (median age 64 years; 24% female), the median ORBI score was 4 (IQR 2–7), and 103 patients (3.8%) developed in-hospital CS. Among all patients, 80% were low risk (ORBI ≤7) with 1.0% developing in-hospital CS; 13% were low-to-intermediate risk (ORBI 8–10) with 5.6% developing CS; 3.1% were intermediate-to-high risk (ORBI 11–12) with 23% developing CS; and 3.9% were high risk (ORBI ≥13), of whom 40% developed in-hospital CS. The score demonstrated strong discrimination (area under the receiver operating characteristic curve [AUC] 0.89; 95% CI: 0.87–0.94) for in-hospital CS and for post-procedural CS (AUC 0.87; 95% CI: 0.83–0.95). In patients with in-hospital CS, 68% developed peri-procedural CS. Among patients with post-procedural, CS the score substantially overestimated CS risk. Conclusions: The ORBI risk score performed well at predicting in-hospital CS but markedly overestimated post-procedural CS risk. As post-procedural CS is the clinically relevant endpoint for a model incorporating post-procedural variables, the ORBI score requires recalibration before it can be used to guide post-PCI decisions.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →